Discover why Eli Lilly and Company is set for a strong 2024 with a robust pipeline, solid financials, and strategic growth ...

Martin says ‘key objective’ has been ‘to convey complexity of pharmaceutical story and how Ireland is part of ‘integrated supply chain’ ...

Hims & Hers has risen since November 2024, outperforming the S&P 500. Click here to see why HIMS stock is a Buy.

Alyssa Tomkins didn’t set out to become one of the country’s most prominent public law litigators. With an engineering ...

Q4 2024 Earnings Call Transcript March 28, 2025 Operator: Ladies and gentlemen, good afternoon. My name is Abby, and I will ...

Rising prevalence of cardiovascular diseases and rapid advancements in minimally invasive procedures are fueling the growth ...

Expanding international reach remains a key pillar of the government’s strategy, with state-owned pharmaceutical companies actively increasing their presence across Africa, the Middle East, and beyond ...

Driven by its Pharmaceutical Activities, Roquette's 2024 Results Demonstrate the Resilience of its Integrated Business Model ...

In this article, we are going to look at where BioMarin Pharmaceutical Inc. (NASDAQ ... and expedite drug development, according to Genetic Engineering and Biotechnology News.

As global markets grapple with economic uncertainty and inflation fears, Asian equities present a unique landscape where small-cap stocks may offer potential opportunities amid the broader market ...

Total product sales of Advicenne up 9.4% to €4.9m Operating cash consumption below €1M by 2025 and significant improvement in cash flow Cash position of €3.2 million on December 31 ...

Industries are using AI, Digital PLM and Digital Thread, resulting in a transparent adoption that helps satisfy changing ...